home / stock / sny / sny news


SNY News and Press, Sanofi From 02/10/26

Stock Information

Company Name: Sanofi
Stock Symbol: SNY
Market: NASDAQ
Website: sanofi.com

Menu

SNY SNY Quote SNY Short SNY News SNY Articles SNY Message Board
Get SNY Alerts

News, Short Squeeze, Breakout and More Instantly...

SNY - Oakmark International Strategy adds Unilever, Sanofi in Q4, exits Novartis

2026-02-10 09:33:04 ET More on related tickers Novartis: Value Price, Growth Pipeline Magnum Ice Cream rallies to a post-Unilever separation high Sanofi signs share buyback for up to €1B Read the full article on Seeking Alpha For further detail...

SNY - Sanofi's rilzabrutinib gains breakthrough therapy status in US, orphan drug designation in Japan

2026-02-09 01:33:54 ET Read the full article on Seeking Alpha For further details see: Sanofi’s rilzabrutinib gains breakthrough therapy status in US, orphan drug designation in Japan

SNY - Oakmark International Strategy Q4 2025 New Investments And Divestments

2026-02-08 12:20:00 ET ... Read the full article on Seeking Alpha For further details see: Oakmark International Strategy Q4 2025 New Investments And Divestments

SNY - Rezurock® now reimbursed in Ontario and British Columbia for people living with chronic graft-versus-host disease (GVHD)

Rezurock® now reimbursed in Ontario and British Columbia for people living with chronic graft-versus-host disease (GVHD) Canada NewsWire Three provinces now cover Rezurock ® (belumosudil) through their provincial formularies for adult and pediatric patients 12 years and ...

SNY - Sanofi signs share buyback for up to Euro1B

2026-02-03 01:23:36 ET Read the full article on Seeking Alpha For further details see: Sanofi signs share buyback for up to €1B

SNY - Sanofi's venglustat demonstrates mixed results in late-stage rare disease trials

2026-02-02 14:46:15 ET More on Sanofi Sanofi (SAN:CA) Q4 2025 Earnings Call Transcript Sanofi 2025 Q4 - Results - Earnings Call Presentation Sanofi (SAN:CA) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript Sanofi anticipates profitable gro...

SNY - Regeneron: Expect Double-Digit Growth In 2026

2026-01-31 08:33:47 ET Regeneron ( REGN ) closed slightly lower yesterday after reporting Q4 2025 results that were slightly better than the market consensus, and providing expense guidance for 2026. However, there were no major surprises, as the company pre-announced Eylea ...

SNY - The DGI Core Portfolio: 2025 Year-End Review

2026-01-31 08:15:00 ET Introduction With the year 2025 already in the rearview mirror, it's a good time to reflect on our investment plans and strategies and see how they handled last year's ups and downs and if they need any adjustments going forward. We present the annual review o...

SNY - Perspective Therapeutics: VMT-A-NET Presses On In SSTR2-Solid Tumor Targeting Space

2026-01-30 15:37:07 ET The last time I spoke about Perspective Therapeutics, Inc. ( CATX ), it was in a Seeking Alpha article entitled " Perspective: VMT01/02 Melanoma Data Coming For Radiotherapeutic Proof-Of-Concept ." With respect to this article, I talked about its radio...

SNY - Sanofi graft-versus-host disease asset Rezurock gains EU approval recommendation

2026-01-30 08:51:51 ET More on Sanofi Sanofi (SAN:CA) Q4 2025 Earnings Call Transcript Sanofi 2025 Q4 - Results - Earnings Call Presentation Sanofi (SAN:CA) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript Sanofi anticipates profitable gro...

Previous 10 Next 10